Novel agents in the treatment of lung cancer: Fourth Cambridge conference

Thomas J. Lynch, Philip D. Bonomi, Charles Butts, Angela M. Davies, Jeffrey Engelman, Ramaswamy Govindan, Roy S. Herbst, John V. Heymach, Bruce E. Johnson, Renato G. Martins, Roman Perez-Soler, Gregory J. Riely, Alan B. Sandler, Lecia V. Sequist, Mark A. Socinski, Kwok Kin Wong, Carol S. Hart

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

The Fourth Cambridge Conference on Novel Agents in the Treatment of Lung Cancer was held in Cambridge, Massachusetts on September 29 to 30, 2006, to discuss ongoing clinical research of novel targeted agents for the treatment of non - small cell lung cancer, along with supportive basic and translational research into the molecular pathways implicated in cancer growth and resistance. New information, conclusions, and recommendations considered significant for the field by the program faculty are summarized below and presented at greater length in the individual articles and accompanying discussions that comprise the full conference proceedings.

Original languageEnglish (US)
Pages (from-to)4583s-4588s
JournalClinical Cancer Research
Volume13
Issue number15
DOIs
StatePublished - Aug 1 2007

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Novel agents in the treatment of lung cancer: Fourth Cambridge conference'. Together they form a unique fingerprint.

  • Cite this

    Lynch, T. J., Bonomi, P. D., Butts, C., Davies, A. M., Engelman, J., Govindan, R., Herbst, R. S., Heymach, J. V., Johnson, B. E., Martins, R. G., Perez-Soler, R., Riely, G. J., Sandler, A. B., Sequist, L. V., Socinski, M. A., Wong, K. K., & Hart, C. S. (2007). Novel agents in the treatment of lung cancer: Fourth Cambridge conference. Clinical Cancer Research, 13(15), 4583s-4588s. https://doi.org/10.1158/1078-0432.CCR-07-0716